AGP Picks
View all

Vanuatu Technology Update
Provided by AGP

Vanuatu Technology Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Technology Update.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 30, 2026

Sekoia Elevate rende concreta la difesa informatica autonoma: dai dati di sicurezza al verdetto in 99 secondi
an hour ago

Sekoia Elevate rende concreta la difesa informatica autonoma: dai dati di sicurezza al verdetto in 99 secondi

Indeterminate GlobeNewswire
DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform
an hour ago

DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform

Indeterminate GlobeNewswire
Asure Software Accelerates Alabama Investment with U of Alabama HR Management Conference Sponsorship Followed by October 23 Gardendale Open House
an hour ago

Asure Software Accelerates Alabama Investment with U of Alabama HR Management Conference Sponsorship Followed by October 23 Gardendale Open House

Indeterminate GlobeNewswire
Rocket Doctor AI to Present at the 153rd National Investment Banking Association (NIBA) Conference in Florida
an hour ago

Rocket Doctor AI to Present at the 153rd National Investment Banking Association (NIBA) Conference in Florida

Indeterminate GlobeNewswire
Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine
an hour ago

Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine

Indeterminate GlobeNewswire
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450
an hour ago

AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450

Indeterminate GlobeNewswire
Rezera Announces Phase 1 Results for Trabzanoflast, which was Generally Well Tolerated and Demonstrated High Central Nervous System Exposure (CNS)
an hour ago

Rezera Announces Phase 1 Results for Trabzanoflast, which was Generally Well Tolerated and Demonstrated High Central Nervous System Exposure (CNS)

Indeterminate GlobeNewswire
ROC Advances to Global Leader for Age Estimation Accuracy in NIST FATE AEV
an hour ago

ROC Advances to Global Leader for Age Estimation Accuracy in NIST FATE AEV

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis
an hour ago

Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis

Indeterminate GlobeNewswire
Immutep Receives ~A$0.86 Million R&D Tax Incentive
an hour ago

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Indeterminate GlobeNewswire
Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment
an hour ago

Parabolic Announces $9.3 Million in Annualized Cost Savings from ConnectAndSell Integration and Business Unit Realignment

Indeterminate GlobeNewswire
Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences
an hour ago

Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences

Indeterminate GlobeNewswire
Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview
an hour ago

Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview

Indeterminate GlobeNewswire
Federal Court Rules in Favor of Genius Group, Denying All Motions to Dismiss in RICO Lawsuit
an hour ago

Federal Court Rules in Favor of Genius Group, Denying All Motions to Dismiss in RICO Lawsuit

Indeterminate GlobeNewswire
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
2 hours ago

MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy

Indeterminate GlobeNewswire
AGM Group Advances AI Inference Strategy, Storage Integration and Server Deliveries
2 hours ago

AGM Group Advances AI Inference Strategy, Storage Integration and Server Deliveries

Indeterminate GlobeNewswire
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
2 hours ago

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Indeterminate GlobeNewswire
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
2 hours ago

Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings

Indeterminate GlobeNewswire
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
2 hours ago

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire
Ocugen to Participate in Upcoming Scientific Conferences
2 hours ago

Ocugen to Participate in Upcoming Scientific Conferences

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Vanuatu Technology Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.